Skip to Content

GG 614 GG 614 (Ranitidine Hydrochloride 150 mg)

Pill with imprint GG 614 GG 614 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Ranitidine is used in the treatment of duodenal ulcer; gerd; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 614 GG 614

Ranitidine hydrochloride 150 mg GG 614 GG 614
Ranitidine hydrochloride 150 mg GG 614 GG 614 Front
Ranitidine hydrochloride 150 mg GG 614 GG 614 Back
Ranitidine hydrochloride 150 mg GG 614 GG 614

Ranitidine Hydrochloride

Imprint
GG 614 GG 614
Strength
150 mg
Color
Brown
Size
16.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC)
00781-2855
Inactive Ingredients
ammonia, corn starch, FD&C Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 6, gelatin, magnesium stearate, propylene glycol, silicon dioxide, sodium lauryl sulfate, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "GG 614 GG 614"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.